BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,934,000 | -99.0% | 19,406 | -99.0% | 0.01% | -99.0% |
| Q2 2022 | $281,021,000 | -1.3% | 1,928,624 | -19.7% | 0.58% | +7.2% |
| Q1 2022 | $284,720,000 | -26.2% | 2,401,284 | -14.2% | 0.54% | -24.3% |
| Q4 2021 | $385,657,000 | +2.1% | 2,798,457 | +3.0% | 0.71% | -54.6% |
| Q3 2021 | $377,583,000 | +42.3% | 2,718,185 | -0.5% | 1.57% | +30.7% |
| Q2 2021 | $265,259,000 | +39.8% | 2,732,368 | -1.6% | 1.20% | +37.9% |
| Q1 2021 | $189,771,000 | -13.4% | 2,776,467 | +8.6% | 0.87% | -26.7% |
| Q4 2020 | $219,121,000 | +33.3% | 2,556,552 | +1.1% | 1.19% | +12.8% |
| Q3 2020 | $164,335,000 | -10.1% | 2,527,850 | +1.1% | 1.05% | -17.9% |
| Q2 2020 | $182,880,000 | +109.6% | 2,501,444 | -2.4% | 1.28% | +47.1% |
| Q1 2020 | $87,234,000 | +539.5% | 2,563,443 | +923.1% | 0.87% | +826.6% |
| Q4 2019 | $13,640,000 | -39.2% | 250,562 | -53.4% | 0.09% | -46.6% |
| Q3 2019 | $22,437,000 | +79.2% | 537,797 | +88.1% | 0.18% | +70.9% |
| Q2 2019 | $12,522,000 | +1615.3% | 285,961 | +1914.4% | 0.10% | +3333.3% |
| Q1 2019 | $730,000 | – | 14,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |